Bioceres Lenders Claim Default, And Dilution Risks Are Higher Than Ever

Bioceres reported 1Q26 results with continued revenue declines but improved gross margins and significant OpEx reductions, boosting profitability. BIOX faces severe financial risks, including default claims and lawsuits to accelerate over $100 million in debt, which it cannot cover with current cash. Equity holders face high dilution risk from convertible notes and potential asset sales, as the company cannot be evaluated as a going concern.

Seeking Alpha • Nov 20, 2025

Bioceres Crop Solutions Corp. (BIOX) Q1 2026 Earnings Call Transcript

Bioceres Crop Solutions Corp. ( BIOX ) Q1 2026 Earnings Call November 13, 2025 8:30 AM EST Company Participants Paula Savanti - Head of Investor Relations Federico Trucco - Executive Chairman & CEO Conference Call Participants Austin Moeller - Canaccord Genuity Corp., Research Division Presentation Operator Good morning all, and thank you for joining us on today's Bioceres Crop Solutions Fiscal First Quarter 2026 Financial and Operational Results. My name is Drew, and I'll be the operator on the call today.

Seeking Alpha • Nov 13, 2025

Bioceres Crop Solutions Reports Fiscal First Quarter 2026 Financial and Operational Results

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal first quarter ended September 30, 2025. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons.

Business Wire • Nov 12, 2025

Bioceres Crop (BIOX) Reports Q1 Loss, Lags Revenue Estimates

Bioceres Crop (BIOX) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.09 per share a year ago.

Zacks Investment Research • Nov 13, 2025

Bioceres Crop Solutions to Host Fiscal First Quarter 2026 Financial Results Conference Call on Thursday, November 13, 2025 at 8:30 a.m. Eastern Time

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or the “Company”), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Thursday, November 13, 2025 at 8:30 a.m. Eastern Time to discuss its results for the fiscal first quarter ended September 30, 2025. A press release detailing these results will be.

Business Wire • Oct 30, 2025

Bioceres Crop Solutions and Colorado Wheat Research Foundation Partner to Advance Climate-Resilient HB4® Wheat in the U.S.

ROSARIO, Argentina & FORT COLLINS, Colorado--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) and the Colorado Wheat Research Foundation (CWRF) today announced a strategic collaboration to jointly develop and commercialize HB4® wheat in the United States. The agreement combines Bioceres' proprietary HB4® technology, with CWRF's leadership in U.S. wheat innovation to create a next generation wheat production system. This system is designed to integrate climate resilience and environ.

Business Wire • Sep 23, 2025

Bioceres At Its Worst Juncture, Equity Dilution Seems Very Possible

Bioceres reported a disastrous year with sales down 30%, margins collapsing, and large unexplained debt losses, resulting in a $60 million net loss. The company faces severe liquidity and capital allocation risks, with high-interest debt, unclear disclosures, and increased dilution risk from convertible notes. Management and board instability, along with poor reporting transparency, further undermine confidence in Bioceres' ability to navigate its challenges.

Seeking Alpha • Sep 10, 2025

Bioceres Crop Solutions Corp. (BIOX) Q4 2025 Earnings Call Transcript

Bioceres Crop Solutions Corp. (NASDAQ:BIOX ) Q4 2025 Earnings Call September 9, 2025 8:30 AM EDT Company Participants Paula Savanti - Head of Investor Relations Federico Trucco - Executive Chairman & CEO Conference Call Participants Kristen Owen - Oppenheimer & Co. Inc., Research Division Benjamin Klieve - Lake Street Capital Markets, LLC, Research Division Austin Moeller - Canaccord Genuity Corp., Research Division Brian Kemp Dolliver - Brookline Capital Markets, LLC, Research Division Presentation Operator Welcome all to the Bioceres Crop Solutions Fiscal Fourth Quarter and Full Year 2025 Financial Results. My name is Drew, and I'll be the operator on the call today.

Seeking Alpha • Sep 9, 2025

Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2025 Financial and Operational Results

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal fourth quarter ended June 30, 2025. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in t.

Business Wire • Sep 9, 2025

Bioceres Crop Solutions: Waiting For Gross Profit To Turn (Downgrade)

Downgrade Bioceres Crop Solutions Corp. to Hold due to Argentina's volatile currency, credit constraints, and a challenging shift in the seed sales model. Recent results show sharply lower revenues, deeper losses, but disciplined cash management, and a focus on cost reductions going forward. Valuation sits at 3.5x gross profit and 8.5–11x EV/EBITDA, but earnings risk and potential dilution remain high.

Seeking Alpha • Sep 9, 2025